Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtiss, L. K.
Right arrow Articles by Witztum, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtiss, L. K.
Right arrow Articles by Witztum, J. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 34, Issue 5 452-461, Copyright © 1985 by American Diabetes Association


ARTICLES

Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects

LK Curtiss and JL Witztum

Nonenzymatic posttranslational glucosylation of the free amine of lysine residues can occur in hyperglycemic diabetic subjects. Using monoclonal antibodies that specifically bind the reduced conjugate of glucose covalently bound to the epsilon amine of lysine, glucitollysine, plasma lipoprotein glucosylation was demonstrated by radioimmunoassays in all subjects tested. Lipoproteins isolated from the plasma of diabetic subjects in poor metabolic control contained up to 33-fold increases in glucitollysine residues/mg of isolated lipoprotein protein, and on an absolute basis contained between 36 and 383 nmol of glucitollysine in their total lipoprotein fraction compared with normals, who had a mean of 2.9 +/- 0.06 nmol. The majority of the glucosylated protein in the d less than 1.125 g/ml fraction was present in the triglyceride-rich lipoproteins of hyperglycemic subjects, whereas the majority of the glucosylated protein in the d less than 1.125 g/ml fraction of euglycemic subjects was present in the high-density lipoproteins (HDL). A number of immunochemical approaches were used to demonstrate that, in diabetic plasma, apo AI, apo AII, apo B, apo CI, apo E, and albumin were glucosylated. Detailed studies of the apoproteins of a d less than or equal to 1.019 g/ml lipoprotein fraction and of an HDL fraction isolated from a hyperglycemic diabetic subject indicated that glucitollysine-specific antibodies can be used to preparatively isolate proteins containing glucosylated amino acid residues so that the extent of glucosylation in specific proteins can be measured. The results indicate that some of the lysine residues of the apoproteins can be modified in hyperglycemic diabetic subjects by the covalent attachment of glucose. The possible significance of these observations is discussed.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
J. W. Stephens, M. M. Sozen, R. A. Whittall, M. J. Caslake, D. Bedford, J. Acharya, S. J. Hurel, and S. E. Humphries
Three Novel Mutations in the Apolipoprotein E Gene in a Sample of Individuals with Type 2 Diabetes Mellitus
Clin. Chem., January 1, 2005; 51(1): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. R. Tannock, K. L. Olin, P. H. R. Barrett, T. N. Wight, and A. Chait
Triglyceride-Rich Lipoproteins from Subjects with Type 2 Diabetes Do Not Demonstrate Increased Binding to Biglycan, a Vascular Proteoglycan
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 35 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. A. Sobenin, V. V. Tertov, and A. N. Orekhov
Optimization of the assay for sialic acid determination in low density lipoprotein
J. Lipid Res., November 1, 1998; 39(11): 2293 - 2299.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
H. Sonmez, S. Suer, T. Ulutin, E. Kokoglu, and N. Ucisik
The Relationship of Various Factors in the Pathogenesis of Atherosclerosis
Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 105 - 110.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Igau, G. Castro, V. Clavey, C. Slomianny, R. Bresson, P. Drouin, J.-C. Fruchart, and C. Fievet
In Vivo Glucosylated LpA-I Subfraction : Evidence for Structural and Functional Alterations
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2830 - 2836.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M.-X. Fu, J.ús R. Requena, A. J. Jenkins, T. J. Lyons, J. W. Baynes, and S. R. Thorpe
The Advanced Glycation End Product, N[IMAGE]-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
J. Biol. Chem., April 26, 1996; 271(17): 9982 - 9986.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Palinski, T. Koschinsky, S. W. Butler, E. Miller, H. Vlassara, A. Cerami, and J. L. Witztum
Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits
Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 571 - 582.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Makino, J. W. Furbee Jr, A. M. Scanu, and G. M. Fless
Effect of Glycation on the Properties of Lipoprotein(a)
Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 385 - 391.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1985 by the American Diabetes Association.